|
Jan 5
|
LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th
|
|
Dec 29
|
Roche to buy part of LumiraDx diagnostics platform for $295 million
|
|
Dec 29
|
LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
|